Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    ADYX Net Margin

    As of 2025-07-04, the Net Margin of Adynxx Inc (ADYX) is -379.8%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    ADYX Net Margin - Historical Value
    DateValue
    2018-12-31 -379.8%
    2017-12-31 -1273.3%
    2016-12-31 -173.3%
    2015-12-31 -213.7%
    2014-12-31 -531.6%
    2013-12-31 -1222.5%
    2012-12-31 -399.2%
    2011-12-31 -756.8%
    2010-12-31 -234.8%
    2009-12-31 -
    ADYX Net Margin - Peers Comparison
    TickerNameValue
    ANTHAnthera Pharmaceuticals Inc-38291.7%
    ARNIArno Therapeutics Inc-
    BGESBio-Bridge Science Inc-5020%
    BIEIPremier Graphene Inc-2622.3%
    BSSPBaseline Productions Inc-402.8%
    CAPSCapstone Holding Corp13.9%
    CXBSCorix Bioscience Inc-638.6%
    DNAGDNAPrint Genomics Inc-507.6%
    ENDVEndonovo Therapeutics Inc-13648.7%
    HXBMHelix BioMedix Inc-214.4%
    MBCIMabCure Inc-2453%
    MBI.H.VMany Bright Ideas Technologies Inc73.9%
    MRPIMera Pharmaceuticals Inc-62%
    NNBPNanobac Pharmaceuticals Inc-36527.8%
    NSTMNovelstem International Corp-26942%
    OVITOncovista Innovative Therapies Inc-1496%
    PANCPanacos Pharmaceuticals Inc-20810.6%
    PLPLPlandai Biotechnology Inc-1467.1%
    PPCBPropanc Biopharma Inc-
    PPMDProtide Pharmaceuticals Inc-19.2%
    PROTStromacel Inc-5322.5%
    PRTXProtalex Inc-
    SPHSSophiris Bio Inc-223%
    TLOGTetraLogic Pharmaceuticals Corp-
    WAVE.VWaverley Pharma Inc-199.2%
    WWHCW World Corp-
    XENOXeno Transplants Corp-
    XSNXNovAccess Global Inc-596.9%
    Tickers added to watchlist